EOLS
NASDAQ · Pharmaceuticals
Evolus Inc
$7.05
-0.42 (-5.62%)
Open$7.04
Previous Close$7.47
Day High$7.28
Day Low$6.41
52W High$9.31
52W Low$3.86
Volume—
Avg Volume802.1K
Market Cap451.45M
P/E Ratio—
EPS$-0.53
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+627.5% upside
Current
$7.05
$7.05
Target
$51.29
$51.29
$37.24
$51.29 avg
$70.77
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 295.18M | 234.29M | 74.40M |
| Net Income | -51,292,942 | -36,640,723 | 20.76M |
| Profit Margin | -17.4% | -16.5% | 27.9% |
| EBITDA | -26,209,989 | -19,763,068 | 38.85M |
| Free Cash Flow | — | — | 15.01M |
| Rev Growth | +26.0% | +26.0% | +16.8% |
| Debt/Equity | 22.00 | 22.00 | 0.90 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |